What sector does Nephro Care India Limited belong to?

Nephro Care India Limited operates in the Healthcare sector, specifically the Hospital industry, and is listed on the NSE.

What is the current share price of NEPHROCARE?

As of the latest available quote, NEPHROCARE traded at ₹234.80. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of NEPHROCARE?

Nephro Care India Limited has a price-to-earnings (P/E) ratio of about 115.10. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of NEPHROCARE?

The market capitalisation of Nephro Care India Limited is approximately ₹154 Cr.

Is Nephro Care India Limited profitable?

For its latest reported financial year, Nephro Care India Limited recorded a net profit margin of about 3.80%.

Does NEPHROCARE pay a dividend?

Nephro Care India Limited does not currently show a dividend yield in our data.

What is the return on equity (ROE) of NEPHROCARE?

Nephro Care India Limited has a return on equity (ROE) of about 5.93%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of NEPHROCARE?

Over the past 52 weeks, NEPHROCARE has traded between a low of ₹50.05 and a high of ₹165.95.

Nephro Care India Limited

NEPHROCARE NSE Healthcare Hospital

₹234.80

-6.27%

Delayed · cached 15 min

Fair value analysis

NEPHROCARE

Nephro Care India Limited

₹91.45

Close used for this calculation

₹64.27Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

19/100

Profitability4/25

Returns6/25

Balance Sheet3/25

Efficiency6/25

Growth0/25

Weak

Quality radar

Consensus fair value

₹64.27

Above FV

▼ -29.7% against the close used

Model range ₹23.78 – ₹104.65

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹23.78Fair value₹64.27Bull₹104.65

FairClose

52-week traded range

52W low ₹51.7552W high ₹164.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Nephro Care India Limited closed at ₹91.45, 42.3% above the consensus fair value of ₹64.27 drawn from 7 valuation models.

Financial DNA score 19/100 — Weak. P/E of 27.3x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

₹38.23

-58.2%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=8%, r=10%, tg=3%, n=10yr

Graham Number

₹51.06

-44.2%

√(22.5 × EPS × BVPS)

EPS=2.04, BVPS=56.8 · outside Graham range (P/E 27.3, P/B 1.6) — asset-light, treat as a rough floor

P/E Fair Value

₹104.65

+14.4%

EPS × 51.3x (sector P/E)

EPS=2.04, Sector P/E=51.3x

EV/EBITDA

₹77.20

-15.6%

(EBITDA × 10x − Net Debt) ÷ Shares

EBITDA=130M

Book Value (P/B)

₹23.78

-74.0%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=56.8, ROE=5.9%, g=3%, r=10%

Reverse DCF

₹91.45

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 18% | Historical: 0%

Margin of Safety

₹48.49

-47.0%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=64.65, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer